These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18670417)

  • 1. Left ventricular longitudinal systolic dysfunction is an independent marker of cardiovascular risk in patients with hypertension.
    Ballo P; Barone D; Bocelli A; Motto A; Mondillo S
    Am J Hypertens; 2008 Sep; 21(9):1047-54. PubMed ID: 18670417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
    Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental value of subclinical left ventricular systolic dysfunction for the identification of patients with obstructive coronary artery disease.
    Nucifora G; Schuijf JD; Delgado V; Bertini M; Scholte AJ; Ng AC; van Werkhoven JM; Jukema JW; Holman ER; van der Wall EE; Bax JJ
    Am Heart J; 2010 Jan; 159(1):148-57. PubMed ID: 20102881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
    Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of left ventricular systolic and diastolic function by tissue Doppler analysis in patients with hypertension with or without hyperuricemia.
    Tavil Y; Kaya MG; Sen N; Tacoy G; Okyay K; Yazici HU; Yalcin MR; Cengel A
    Blood Press Monit; 2008 Apr; 13(2):79-84. PubMed ID: 18347441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications.
    Colivicchi F; Mettimano M; Genovesi-Ebert A; Schinzari F; Iantorno M; Melina G; Santini M; Cardillo C; Melina D
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):267-72. PubMed ID: 18301144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic index relating 24-hour ambulatory blood pressure to cardiac events in ischemic cardiomyopathy following defibrillator implantation.
    Antonini L; Colivicchi F; Pasceri V; Greco S; Varveri A; Turani L; Kol A; Santini M
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1089-94. PubMed ID: 18834457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study.
    Cicala S; de Simone G; Roman MJ; Best LG; Lee ET; Wang W; Welty TK; Galloway JM; Howard BV; Devereux RB
    Circulation; 2007 Jul; 116(2):143-50. PubMed ID: 17576870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac failure in hypertensive cardiopathy].
    Verdecchia P
    Ital Heart J; 2000 Jun; 1 Suppl 2():72-7. PubMed ID: 10905132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of left ventricular longitudinal and circumferential systolic dysfunction with diastolic function in hypertension: a nonlinear analysis focused on the interplay with left ventricular geometry.
    Ballo P; Nistri S; Cameli M; Papesso B; Dini FL; Galderisi M; Zuppiroli A; Mondillo S;
    J Card Fail; 2014 Feb; 20(2):110-20. PubMed ID: 24361853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between hypertensive urgencies and subsequent cardiovascular events in patients with hypertension.
    Vlcek M; Bur A; Woisetschläger C; Herkner H; Laggner AN; Hirschl MM
    J Hypertens; 2008 Apr; 26(4):657-62. PubMed ID: 18327073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastolic dysfunction of the cardiac allograft and maximal exercise capacity.
    Roten L; Schmid JP; Merz F; Carrel T; Zwahlen M; Walpoth N; Mohacsi P; Hullin R
    J Heart Lung Transplant; 2009 May; 28(5):434-9. PubMed ID: 19416770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.
    Patel JV; Lim HS; Varughese GI; Hughes EA; Lip GY
    Ann Med; 2008; 40(3):215-22. PubMed ID: 18382887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death.
    Hakeem A; Bhatti S; Dillie KS; Cook JR; Samad Z; Roth-Cline MD; Chang SM
    Circulation; 2008 Dec; 118(24):2540-9. PubMed ID: 19047585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the myocardial performance index in ambulatory patients with heart failure: correlation with other clinical and echocardiographic parameters and independent prognostic value.
    Vizzardi E; Chiari E; Faggiano P; D'Aloia A; Bordonali T; Metra M; Cas LD
    Echocardiography; 2010 Feb; 27(2):123-9. PubMed ID: 19765064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.